Resumo

RODRIGUEZ LUGO, Diego Andrés; CORONADO TOVAR, Jorge Julián; SOLANO VILLAMARIN, Giovana Alejandra  e  OTERO REGINO, Wiliam. Primary Biliary Cholangitis. Part 2. State of the Art, Diagnosis, Associated Diseases, Treatment and Prognosis. Rev. gastroenterol. Perú [online]. 2018, vol.38, n.1, pp.64-71. ISSN 1022-5129.

Primary biliary cholangitis (PBC) is a chronic autoimmune cholangiopathy characterized by a selective destruction of biliary epithelial cells of small and medium caliber hepatic ducts, which mainly affects women. The main symptoms are fatigue and pruritus, however, a large proportion of patients may be asymptomatic. The diagnosis is based on AMA titers >1:40, alkaline phosphatase >1.5 times the upper limit for more than 24 weeks and compatible liver histology. It is associated with multiple autoimmune diseases mainly extrahepatic, thyroid diseases, bone diseases, among others. The first line treatment is ursodeoxycholic acid (UDCA), that improves liver function tests and delay the progression to cirrhosis. Currently, there are new treatments and adjuvant therapies on study. The purpose of this review is to offer an update in this topic, which is very important in gastroenterology and internal medicine. We formed an interdisciplinary team to search in the data base Medline thorough PubMed with the keywords describe below, we made a critical lecture of the titles and abstracts of each article to write this paper

Palavras-chave : Cholangitis; Cirrhosis; Pruritus; Jaundice.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )